These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4087824)

  • 1. [Delayed-type skin reaction in children with malignant diseases].
    Ebell W; Schmidt C; Wahn V; Göbel U
    Klin Padiatr; 1985; 197(6):447-52. PubMed ID: 4087824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cellular immunity using skin tests in children with malignant diseases at the time of diagnosis and after therapy].
    Göbel U; Körholz D; Janssen G; Schwamborn D; Jürgens H
    Onkologie; 1987 Jun; 10(3 Suppl):4-7. PubMed ID: 3309761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic evaluation of patients with cancer by delayed hypersensitivity reactions.
    Burdick JF; Wells SA; Herberman RB
    Surg Gynecol Obstet; 1975 Nov; 141(5):779-94. PubMed ID: 128144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The function of the immune system after the treatment of pediatric malignant diseases].
    Gadó J; Schlick B; Bárány O; Németh J; Müller J; Csóka M; Constantin T; Vonnák E; Böcskei R; Hauser P; Kovács G
    Orv Hetil; 2006 Sep; 147(36):1731-8. PubMed ID: 17087017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed hypersensitivity responses of cancer patients to recall antigens using a new "Multitest" applicator.
    Reuben JM; Hersh EM
    Ann Allergy; 1984 Nov; 53(5):390-4. PubMed ID: 6594072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-mediated immunity in healthy and uremic adults assessed by in vivo and in vitro techniques. Validation of delayed hypersensitivity skin testing.
    López M; Jerez J; González M; Arias M
    Allergol Immunopathol (Madr); 1989; 17(1):21-8. PubMed ID: 2750637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune function of successfully treated lymphoma patients.
    King GW; Yanes B; Hurtubise PE; Balcerzak SP; LoBuglio AF
    J Clin Invest; 1976 Jun; 57(6):1451-60. PubMed ID: 932190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell mediated immunity in school children assessed by Multitest CMI skin testing II. Epidemiologic factors affecting immune responsiveness.
    Lesourd BM; Corriel RN; McBryde JL; Kniker WT
    Ann Allergy; 1985 May; 54(5):446-52. PubMed ID: 3994073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Controlled study of unspecific cellular immunity in cancer patients].
    Dominioni L; Dionigi R; Prati U; Cividini F; Cincera M; Pavesi L; Della Cuna GR
    Minerva Med; 1981 Mar; 72(12):733-40. PubMed ID: 6971418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Delayed hypersensitivity in pediatric patients with cancer].
    Rivera Luna R; Munford DM; Wilbur JR
    Bol Med Hosp Infant Mex; 1977; 34(6):11-71. PubMed ID: 588329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed skin hypersensitivity reaction in normal children.
    Kerr AA; Denton RG
    N Z Med J; 1978 Jul; 88(616):57-9. PubMed ID: 360117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous delayed-type hypersensitivity responsiveness in lepromatous and borderline lepromatous leprosy patients as determined by MULTITEST CMI.
    Walsh DS; Villahermosa LG; Balagon MV; Abalos RM; Fajardo TT; Tan EV; Cellona RV; Walsh GP
    Southeast Asian J Trop Med Public Health; 1999 Sep; 30(3):518-26. PubMed ID: 10774662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the delayed skin reaction in chronically ill children].
    Rister M; Roth B; Skopnik H; Liertz KP
    Klin Padiatr; 1986; 198(4):316-20. PubMed ID: 3489861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cell-mediated immunity studied by skin tests in patients receiving intensive care. Prognostic value of repeated tests. Study of some factors predisposing towards anergy (author's transl)].
    Tasseau F; Gaucher L; Nicolas F
    Sem Hop; 1982 Apr; 58(13):781-4. PubMed ID: 6283652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [NHL-BFM 90 therapy study in treatment of malignant non-Hodgkin's lymphoma in children and adolescents. Part 3: An intermediate term analysis of the B-NHL/B-ALL].
    Reiter A; Schrappe M; Yakisan E; Sauter S; Ebell W; Zimmermann M; Hartmann W; Kremens B; Kuhn N; Claviez A
    Klin Padiatr; 1994; 206(4):242-52. PubMed ID: 7967420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of delayed skin hypersensitivity using the multitest in an intensive care unit].
    Kienlen J; Chardon P; Nury G; Lubrano JF; Messmer JC; du Cailar J
    Ann Anesthesiol Fr; 1981; 22(3):285-91. PubMed ID: 6117235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunological cell-type reaction in patients with and without malignant tumors].
    Pavelić Z; Boranić M; Milas L
    Lijec Vjesn; 1973 Feb; 95(2):62-7. PubMed ID: 4121020
    [No Abstract]   [Full Text] [Related]  

  • 18. Malignant non-Hodgkin's lymphoma of childhood and adolescence in Austria--therapy results between 1986 and 2000.
    Attarbaschi A; Mann G; Dworzak M; Trebo M; Urban C; Fink FM; Horcher E; Reiter A; Riehm H; Gadner H;
    Wien Klin Wochenschr; 2002 Dec; 114(23-24):978-86. PubMed ID: 12635465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired cell-mediated immunodepression in acute Chagas' disease.
    Teixeira AR; Teixeira G; Macêdo V; Prata A
    J Clin Invest; 1978 Dec; 62(6):1132-41. PubMed ID: 107195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of surgery, chemotherapy and irradiation on long term outcome of intracranial malignant non-germinomatous germ cell tumors: results of the German Cooperative Trial MAKEI 89.
    Calaminus G; Bamberg M; Jürgens H; Kortmann RD; Sörensen N; Wiestler OD; Göbel U
    Klin Padiatr; 2004; 216(3):141-9. PubMed ID: 15175958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.